搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
12 分钟
Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184
Company to conduct a Phase 1 Drug-Drug Interaction StudyPhase 2 filing on track for Q1 2025SOUTH SAN FRANCISCO, Calif., Oct. 22, 2024 (GLOBE ...
PharmiWeb
17 分钟
Thrombocytopenia Treatment Market Expected to Reach USD 10 Billion by 2033, Growing at a ...
Global Thrombocytopenia Treatment IndustryThe global Thrombocytopenia Treatment Market is projected to experience significant ...
2 小时
Gilead to Present Latest Research Across Key Liver Disease Indication at the American ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced new research to be presented at The Liver Meeting® 2024, hosted by the ...
Le Lézard
2 小时
Otsuka Announces Positive Interim Results from the Phase 3 Trial of Sibeprenlimab for the ...
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical, Co. Ltd. (Otsuka), today announce positive topline interim data from the ongoing Phase 3 clinical trial of ...
3 小时
SFA Therapeutics Strengthens Intellectual Property in Autoimmune Disease and Hepatocellular ...
SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for ...
3 小时
Rectify Pharma Announces Positive Functional Modulator RTY-694 as Development Candidate for ...
RTY-694 is a potent, orally active ABCB4/BSEP positive functional modulator (PFM) that improves bile composition and enhances bile flowThe ...
4 小时
Editas Medicine Announces Progress Towards 2024 Goals, Including Achievement of In Vivo ...
Editas Medicine Announces Progress Towards 2024 Goals, Including Achievement of In Vivo Preclinical Proof of Concept and ...
The Financial Express
4 小时
Tuberculosis can change liver metabolism and cause diabetes, new study reveals
The study first used laboratory models of pulmonary TB to examine the changes happening within the liver during the early ...
The Point
4 小时
‘Number of liver cancer cases are predicted to rise globally’
Professor Ramou Njie made this disclosure recently during her presentation as part of activities marking liver cancer ...
FierceBiotech
4 小时
Rectify's new lead candidate improves bile composition, reduces inflammation in mice with ...
Three years after raising $100 million in series A funds, the Atlas Venture-backed biotech has chosen a lead drug candidate.
devdiscourse
4 小时
Unveiling the TB-Diabetes Connection: How Tuberculosis Alters Liver Metabolism
A study has shown that tuberculosis disrupts glucose metabolism in the liver, potentially leading to diseases like diabetes.
clinicaltrialsarena
4 小时
Madrigal Pharmaceuticals enrols patients in Phase III trial of NASH cirrhosis drug
Madrigal Pharmaceuticals has finished enrolling patients in a trial of Rezdiffra, a drug candidate for compensated NASH ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈